Arji Naima, Busson Marc, Iraqi Ghali, Bourkadi Jamal Eddine, Benjouad Abdelaziz, Boukouaci Wahid, Lahlou Ouafae, Ben Amor Jouda, Krishnamoorthy Rajagopal, Charron Dominique, El Aouad Rajae, Tamouza Ryad
Immunology and Virology Department, National Institute of Hygiene, Agdal, Rabat, Morocco.
J Infect Dev Ctries. 2012 Jan 12;6(1):73-8. doi: 10.3855/jidc.1925.
Both monocyte chemoattractant protein-1 (MCP-1), also designated officially as chemokine (C-C motif) ligand 2 (CCL2), and interleukin-12 p40 (IL-12 p40) molecules, encoded by polymorphic genes, are central components of the immune response to infection by Mycobacterium tuberculosis (Mtb). Their genetic diversity has previously been associated with the outcome of tuberculosis (TB) infection. We investigated whether the MCP-1 -2518 A/G and the IL-12B (p40) +1188 A/C polymorphisms influence susceptibility to or resistance against pulmonary tuberculosis (PTB) in a Moroccan population group.
Genomic DNA from 337 patients along with 204 healthy controls were genotyped for the above-mentioned genetic variations using polymerase chain reaction-based restriction fragment length polymorphism assay.
We found a higher prevalence of homozygous MCP-1 -2518 G allele in healthy individuals than in patients (pc = 0.04; odds ratio = 0.35; 95% confidence interval = 0.13 - 0.86), suggesting a potential protective effect, whereas analysis of IL-12B +1188 variation failed to reveal any such association.
Our results are in agreement with recent findings in Ghanaian patients, complying with the known genetic admixture of the Moroccan population.
单核细胞趋化蛋白-1(MCP-1),也被正式命名为趋化因子(C-C基序)配体2(CCL2),以及由多态性基因编码的白细胞介素-12 p40(IL-12 p40)分子,都是结核分枝杆菌(Mtb)感染免疫反应的核心组成部分。它们的基因多样性此前已与结核病(TB)感染的结果相关联。我们调查了MCP-1 -2518 A/G和IL-12B(p40)+1188 A/C多态性是否会影响摩洛哥人群中肺结核(PTB)的易感性或抵抗力。
采用基于聚合酶链反应的限制性片段长度多态性分析,对337例患者和204例健康对照的基因组DNA进行上述基因变异的基因分型。
我们发现健康个体中纯合MCP-1 -2518 G等位基因的患病率高于患者(pc = 0.04;优势比 = 0.35;95%置信区间 = 0.13 - 0.86),表明可能具有保护作用,而对IL-12B +1188变异的分析未发现任何此类关联。
我们的结果与加纳患者的近期研究结果一致,符合摩洛哥人群已知的基因混合情况。